Matches in Nanopublications for { ?s ?p "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP594199.RADlZHp2C1kj1UGuAc7xLS-V58Sp4Wb9YvSdsuBG4F-4s130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594199.RADlZHp2C1kj1UGuAc7xLS-V58Sp4Wb9YvSdsuBG4F-4s130_provenance.
- NP217081.RA_d085gj4KDHBrsx7TKJKOZ7k_VXKAtlyDnuE1PMwEgU130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217081.RA_d085gj4KDHBrsx7TKJKOZ7k_VXKAtlyDnuE1PMwEgU130_provenance.
- NP613951.RAG6LlqJley90jY9IBB2hOgjoxT-3HxVgyYM0J4eIqSk4130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613951.RAG6LlqJley90jY9IBB2hOgjoxT-3HxVgyYM0J4eIqSk4130_provenance.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.
- NP478071.RAzV1HBu2qrod6q0bXuAxDhiwyN7pppR_oMKdQscrJH-w130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478071.RAzV1HBu2qrod6q0bXuAxDhiwyN7pppR_oMKdQscrJH-w130_provenance.
- NP477482.RAdlMxuETI5-is4H1UmYp3pUqwQRpnW2eZL_uFoYoOPaE130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477482.RAdlMxuETI5-is4H1UmYp3pUqwQRpnW2eZL_uFoYoOPaE130_provenance.
- NP476290.RAGuXBPeH0Gde3WbWz4yxrRz2l4cPB7-yrqBRrmk2fqJs130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476290.RAGuXBPeH0Gde3WbWz4yxrRz2l4cPB7-yrqBRrmk2fqJs130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878374.RAHXwBo4gjrGE5e5R-kE2rsYSzdqjwHOPyuzjMO8jqqbU130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878374.RAHXwBo4gjrGE5e5R-kE2rsYSzdqjwHOPyuzjMO8jqqbU130_provenance.